Research News and Research

RSS

Postmenopausal women who take antidepressants face increased risk for stroke and death

Postmenopausal women who take antidepressants face a small but statistically significant increased risk for stroke and death compared with those who do not take the drugs. The new findings are from the federally-funded, multi-institution, Women's Health Initiative Study sponsored by the National Institutes of Health, and the results are published in the December 14 online edition of Archives of Internal Medicine.

14 Dec 2009

DeParle gets GOP cold shoulder on health reform

Politico: "Senate Republicans say they want to 'smoke out' Democratic senators who could help them bring down the health care bill, and so far, they think they've found one in Sen. Jim Webb. With all the attention focused on four other fence-sitting moderates, Webb has voted with Republicans six times on the first series of amendments on the Senate floor — giving GOP leaders some hope that the unpredictable Virginian could buck his party in the end and block the bill" (Raju, 12/14).

14 Dec 2009

Data mining by drug companies raises concern

The Los Angeles Times examines a practice called data mining in which drug companies track how doctors prescribe medications by obtaining data from pharmacies and health insurers.

14 Dec 2009

Tea and coffee can reduce risk of type 2 diabetes

Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.

14 Dec 2009

McClatchy series examines Africa's population

"Although it's frequently portrayed as a continent decimated by epidemics, starvation and war, Africa is gripped by one of the greatest population explosions ever recorded.

14 Dec 2009

Companies shed more light on health bill lobbying

USA Today: "Sweeping ethics rules passed by Congress in 2007 require corporate interests that lobby Washington to reveal more information than ever, such as how much they donate to politicians' favorite charities.

14 Dec 2009

ZYPREXA RELPREVV approved by FDA

The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.

14 Dec 2009

Scientists present new research on adipocyte regulation

The ninth Colloque Médecine et Recherche of la Fondation Ipsen devoted to Endocrinology, held in Paris on December 4, 2009, has reviewed the recent progress in understanding the regulation of fat storage in the body and the consequences of the breakdown of this regulation.

14 Dec 2009

Research uncovers structural basis for multifunctionality of aminoacyl tRNA synthetases

Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.

14 Dec 2009

US journal identifies fundamental factors behind failed EPR projects

Large-scale electronic patient record (EPR) programmes promise much but sometimes deliver little, according to a new study by UCL researchers that reviewed findings from hundreds of previous studies from all over the world.

14 Dec 2009

Researchers develop new method for individually adapted implants

Researchers at Mid Sweden University, together with Professor Jan Hirsch and Consultant Per Dérand, oral & maxillofacial surgeons at Uppsala University Hospital and Mälarsjukhuset Hospital, respectively, have developed an entirely new method for individually adapted implants.

14 Dec 2009

Premature newborn boys have poorer prognosis compared to newborn girls, says study

Among premature births - children born before the 37th week of pregnancy - newborn boys have a poorer prognosis than newborn girls. In her dissertation at Lund University in Sweden, the physician Emma Elsmén Steen has explored why male gender constitutes a risk factor for greater morbidity in these infants.

14 Dec 2009

First Edition: December 14, 2009

Today's headlines reflect the mounting pressure in the Senate regarding the pending health overhaul bill -- especially as the clock ticks closer to the Christmas holiday.

14 Dec 2009

Vivakor launches new website to promote its remarkable VivaThermic Vial

Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.

14 Dec 2009

Recipients of ‘2009 Putting Patients First grant’ program announced

Recognizing the need for programs that improve patient safety and quality care, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the six recipients of the second annual Putting Patients First grant program.

14 Dec 2009

Researchers discover enzyme activity behind sleep deprivation

There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration of an enzyme in the brain. These are the conclusions of research published by Rubicon-grant winner Robbert Havekes and colleagues in the 22 October issue of Nature.

14 Dec 2009

Psychology professor examines factors that motivate men to go on shooting rampage

Maurice Clemmons' fatal shooting of four Washington state police officers once again put the spotlight on mass murder in the United States. Coming on the heels of the November killings at Fort Hood, the Washington case raised questions about the factors that motivate men to go on a shooting rampage.

14 Dec 2009

MHI launches new research program in heart failure

The Montreal Heart Institute (MHI) and its Foundation (MHIF) launched today the Carolyn and Richard J. Renaud Research Chair in Heart Failure, the first of its kind in Québec.

14 Dec 2009

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers.

14 Dec 2009

Hormone therapy: An important treatment option for post-menopausal women

In connection with the New York Times’ recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper’s account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.

14 Dec 2009